43results about How to "Avoid Biosafety Hazards" patented technology

The invention discloses humanized genetic recombinant human-like collagen produced by eukaryotic bacteria. The humanized genetic recombinant human-like collagen has amino acid with the total length of 474, and is formed by connecting two sections of completely-identical human III-type collagen sections in series; the end C is connected with six histidine residue groups serving as specificity affinity purification markers. The performance of the genetic recombination human-like collagen is superior to animal collagens and original nuclear engineering bacteria recombinant collagens; and with the specificity affinity purification markers, the high-purity product is easily acquired.

The present invention relates to one kind of recombinant Newcastle disease Lasota low virulent vaccine strain expressing wild or mutant bird flu virus H5 subtype HA protein, and is especially recombinant Newcastle disease Lasota low virulent vaccine strains prLasota-H5wtHA and rLasota-H5mutHA. The present invention also discloses the preparation process of the recombinant Newcastle disease Lasota low virulent vaccine strain and the application of the recombinant Newcastle disease Lasota low virulent vaccine strain in preparing vaccine for preventing bird flu.

The invention discloses a control system for medical laboratory quality management system documents and a normalized control method thereof. The intelligent control system comprises a system parameter setting module, a system document parameter setting module, a file editing module, a file approving module, a document operation reminding module, a document referring module, a document reviewing module, a table compiling module, a record filling module and a record referring module. According to the control system for the medical laboratory quality management system documents and the normalized control method thereof provided by the invention, under the condition of meeting quality management standard, the compiling and alteration for the documents, the reviewing and approving for the documents, the referring and reviewing for the documents, the editing for record tables and the filling and reviewing for records can be realized in an informationized manner; simple operation is supported; the document conversion and the dynamic compiling of the record tables can be quickly realized; the quality system documents can be simply, efficiently and comprehensively controlled.

The invention belongs to the technical field of genetic engineering, particularly relates to a genome editing method based on a zymomonas mobilis endogenous CRISPR-Cas system and application thereof and aims at taking Z.mobilis 4 as a type strain and utilizing the I-F type CRISPR-Cas system coded by its genome to establish a genome editing platform. A powerful tool is provided for basic research and application research in the strain and similar cells, and the development of metabolic engineering, system biology and synthetic biology is promoted. According to the technical scheme, the genome editing method is characterized by comprising the steps of constructing a plasmid containing an artificial CRISPR expression unit; selecting a guide RNA sequence aiming at a target site; constructing aguide RNA primer sequence on the plasmid containing the artificial CRISPR expression unit; constructing a donor DNA sequence on a vector to obtain an editing plasmid; transforming the editing plasmidinto competent cells for editing.

The invention relates to a clostridium perfringens Beta toxin recombination subunit vaccine and a production method thereof. The prepared clostridium perfringens Beta toxin recombination subunit vaccine is produced by using a recombination clostridium perfringens Beta toxin protein which is processed by codon optimization and contains 4 amino acid mutations, namely integrity and spatial conformation of a natural toxin protein are reserved in the greatest degree, so immunogenicity of the natural toxin protein is kept, and a biological potential safety hazard caused by the single amino acid mutation is avoided. The vaccine further has the advantages of simple preparation process, low immunizing dose, good vaccine efficacy and the like. Compared with a current commercial clostridium perfringens natural toxin inactivated vaccine in China, a bio-safety risk in a vaccine production process is greatly reduced. The vaccine is a perfect candidate vaccine for updating a current C-type clostridium perfringens toxin vaccine in China. In addition, while a mixed vaccine is prepared by the vaccine with other antigens, the mixed vaccine can be prepared without increasing a using dose of the mixedvaccine.

The invention discloses a cell preserving and centrifugal filtering device. The cell preserving and centrifugal filtering device comprises a transparent cylindrical hollow tube, wherein a funneled filter funnel is arranged on the upper inner side of the transparent cylindrical hollow tube; a guide pipe is arranged at the bottom of the filter funnel; a filter screen is arranged between the guide pipe and the filter funnel; the bottom of the transparent cylindrical hollow tube is in threaded connection with a bottom cover; a support pillar is arranged on the upper surface of the bottom cover; a circular-arc-shaped groove is formed in one side of the transparent cylindrical hollow tube; a glass slide is inserted into the transparent cylindrical hollow tube through the circular-arc-shaped groove. The cell preserving and centrifugal filtering device has the advantages that the structure is simple, the functions are diversified, the working efficiency is effectively improved, consumables are reduced, disorder is prevented, and the probability of cross contamination is reduced.

The invention provides a method for producing beta-mannase by adopting lactic acid bacteria cultured by taking konjaku flour as the carbon source, relating to a method for producing beta-mannase by adopting lactic acid bacteria, for solving the problems that during the producing of mannase by adopting fungi in the prior art, the fermentation period is long, the bacteria for producing mannase has the potential biological safety hazards, and the activity of the lactic acid bacteria in producing the mannase is low. The method comprises the following steps: 1, inoculating lactobacillus plantarum to an MRS solid medium panel, and carrying out culturing; 2, picking single colonies, and carrying out culturing in MRS liquid medium; 3, carrying out centrifugalization, abandoning the supernatant, collecting thalli, and adjusting the cell concentration, thus obtaining the seed solution; 4, inoculating the seed solution to a fermentation medium, thus obtaining fermentation liquor; and 5, centrifugalizing the fermentation liquor, abandoning the thalli, and taking the supernatant, thus obtaining the mannase crude enzyme. The crude enzyme produced by adopting the method provided by the invention is high in enzyme activity, low in production cost, and short in production period, and the produced bacterial strain has no biological safety hazards. The method is applied to the field of microbial fermentation enzyme production.

The invention refers to the technical field of disposable vacuum blood sampling, in particular to a self-destructive mechanism of an axial filling adhesive type disposable blood sampling syringe needle. The self-destructive mechanism is composed of a guide cylinder, an upper guide curved face, a positioning hole, a lower guide curved face, a locking pipe, an intubation tube, a piston, an annular bulge, a sac, 502 glue water, a sealing fin, a glue outlet and an annular hollow. The space in the guide cylinder comprises the upper guide curved face, the positioning hole and the lower guide curved face; conical spaces corresponding to the upper guide curved face and the lower guide curved face are in communication with the positioning hole. The bottom part of the locking pipe is bonded with the sac made of polyethylene plastic film. According to the self-destructive mechanism provided by the invention, the inner part of the syringe needle can be blocked, so that the syringe needle is irreversibly destructed; and therefore, the reutilization of the disposable syringe needle by criminals is radically eliminated.

The present invention relates to a non-toxic clostridium perfringens beta-toxin genetic engineering vaccine. The prepared clostridium perfringens beta-toxin recombinant subunit vaccine is produced bycodon-optimized production and multiple-amino-acid-mutation- containing recombinant clostridium perfringens beta-toxin proteins, thus maximally retains integrity and spatial conformation of natural toxin proteins, keeps immunogenicity, and also avoids biosafety hazards brought by single amino acid mutations. The vaccine also has advantages of simple preparation technology, low immune dose, excellent vaccine efficacy, etc., greatly reduces biosafety risks in vaccine production processes compared with current commercial clostridium perfringens natural toxin inactivated vaccines in China, and isan ideal candidate vaccine for upgrading of current type B and type C clostridium perfringens toxin vaccines in China; and when the vaccine and other antigens are commonly used to prepare a combined vaccine, dose of the combined vaccine cannot be increased and the combined vaccine can be prepared.

The invention discloses a biological indicator assisted crushing and culturing device. The device comprises a culture box, a mounting frame and a crusher, wherein the culture box is a colorless and transparent box, the mounting frame is arranged above the culture box, multiple biological indicator storage units are arranged in the mounting frame, and one side of the culture box is connected with acrusher connecting part connected with the crusher detachably. The device can effectively assist crushing of biological indicators, solve the problem of hand pricking or culture medium backflow, assist culture of the biological indicators and avoid biological safety harm caused by inversion leakage of a spore tube. The invention further discloses a use method of the biological indicator assistedcrushing and culturing device.

The invention relates to a method for detecting the drug resistance of antituberculosis drugs based on an overlap-extension PCR. By adopting an overlap-extension PCR method, four drug-resistance related segments of rpoB, embB and katG genes and an inhA promoter are connected and amplified into a fusion segment with the length of about 700 bp in a single tube, drug-resistance mutation information of the four segments is obtained just through a one-time sequencing reaction, and accordingly the condition of drug resistance of some kind of mycobacterium tuberculosis to three kinds of first-line antituberculosis drugs is known. If the method is applied and popularized clinically, the detection cost is greatly reduced, the economic burden of a patient is reduced, and the good social benefit is achieved. In short, by means of the method that the single-tube PCR amplification rpoB-embB-katG-inhA fusion segment is used for sequencing, so that the drug resistance condition of three kinds of first-line antituberculosis drugs is detected, the economic burden is reduced for detection of clinical drug resistance tuberculosis, the detection accuracy is improved, and the method is easy and convenient to implement, accurate and low in cost.

The invention belongs to the field of biotechnology, and in particular relates to a method and application of a high-efficiency genome large fragment deletion method based on a CRISPR-nCas3 system. In the present invention, bioinformatics methods are firstly used to determine the essential genes to be retained and the non-essential genes that can be deleted, and select a non-essential gene with a length of 10Kb as the target knockout large fragment. Then, a spacer sequence is designed on the coding strand and the template strand of the target gene sequence, and two crRNAs transcribed and processed from the spacer sequence work together with the modified nCas3 single-stranded endonuclease to complete the double-sequence analysis of the target DNA sequence. chain breakage. Finally, the artificial CRISPR cluster and the donor DNA sequence were assembled on the carrier, and transformed into Zymomonas mobilis cells by electroporation to complete the editing.

The invention provides an immunosuppressive myocarditis mouse model and a construction method and application thereof. The method comprises the following steps that a male BALB/c mouse of 4-6 weeks old is selected as an experimental mouse for constructing the myocarditis mouse model, and observation and feeding are conducted for three days; after feeding is conducted for three days, a cyclosporine A solution with the preset concentration is injected in an intraperitoneal injection mode, the injection amount each time is 40-50mg/kg of the mouse weight, injection is conducted once every other day, and injection is conducted three times in total; and after the last injection is conducted for one day, the myocarditis mouse model is obtained. According to the immunosuppressive myocarditis mouse model and the construction method and application thereof, cyclosporine A serves as an immunosuppressor, myocarditis is successfully induced according to a specific administration method, myocardial damage is caused, the myocarditis mouse model is constructed, and death does not exist; compared with a mouse model constructed through virus infection and LPS induced inflammation in the prior art, the immunosuppressive myocarditis mouse model has the advantages of being safe and effective, and the tolerance of the experimental mouse is better.